Magnus Walter

Company: Monte Rosa Therapeutics

Job title: Senior Vice President Drug Discovery

Seminars:

Designing, Constructing & Screening Molecular Glue Libraries to Identify Potent & Selective Glues for Neurodegenerative Targets 10:30 am

A highly curated library of molecular glue degraders (MGDs) is a key component of QuEEN, our proprietary MGD discovery engine Property-based design delivers MGDs with tuneable tissue-distribution profiles Access to highly potent, selective and brain-penetrant MGDsRead more

day: Conference Day Two